NCT05726682View on ClinicalTrials.gov

A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 8, 2024

Primary Completion Date

February 12, 2027

Study Completion Date

October 11, 2027

Conditions
Allogenic Stem Cell Transplantation
Interventions
DRUG

SAR445419

Pharmaceutical form: cell suspension Route of administration: Intravenous (IV) injection

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY